185 related articles for article (PubMed ID: 31647396)
21. Beyond the sleep-amyloid interactions in Alzheimer's disease pathogenesis.
Ning S; Jorfi M
J Neurophysiol; 2019 Jul; 122(1):1-4. PubMed ID: 30864847
[TBL] [Abstract][Full Text] [Related]
22. Alzheimer's Disease Mechanisms and Emerging Roads to Novel Therapeutics.
Sala Frigerio C; De Strooper B
Annu Rev Neurosci; 2016 Jul; 39():57-79. PubMed ID: 27050320
[TBL] [Abstract][Full Text] [Related]
23. Amyloid-β and Tau at the Crossroads of Alzheimer's Disease.
Gallardo G; Holtzman DM
Adv Exp Med Biol; 2019; 1184():187-203. PubMed ID: 32096039
[TBL] [Abstract][Full Text] [Related]
24. Amyloid cascade hypothesis: Pathogenesis and therapeutic strategies in Alzheimer's disease.
Barage SH; Sonawane KD
Neuropeptides; 2015 Aug; 52():1-18. PubMed ID: 26149638
[TBL] [Abstract][Full Text] [Related]
25. Cytosolic calcium: Judge, jury and executioner of neurodegeneration in Alzheimer's disease and beyond.
Webber EK; Fivaz M; Stutzmann GE; Griffioen G
Alzheimers Dement; 2023 Aug; 19(8):3701-3717. PubMed ID: 37132525
[TBL] [Abstract][Full Text] [Related]
26. Natural Compounds with Anti-BACE1 Activity as Promising Therapeutic Drugs for Treating Alzheimer's Disease.
Naushad M; Durairajan SSK; Bera AK; Senapati S; Li M
Planta Med; 2019 Nov; 85(17):1316-1325. PubMed ID: 31618777
[TBL] [Abstract][Full Text] [Related]
27. Alzheimer's Disease and Natural Products: Future Regimens Emerging from Nature.
Islam MA; Khandker SS; Alam F; Khalil MI; Kamal MA; Gan SH
Curr Top Med Chem; 2017; 17(12):1408-1428. PubMed ID: 28049401
[TBL] [Abstract][Full Text] [Related]
28. [Development of SPECT Probes for In Vivo Imaging of β-Amyloid and Tau Aggregates in the Alzheimer's Disease Brain].
Watanabe H
Yakugaku Zasshi; 2017; 137(11):1361-1365. PubMed ID: 29093372
[TBL] [Abstract][Full Text] [Related]
29. The interactions of p53 with tau and Aß as potential therapeutic targets for Alzheimer's disease.
Jazvinšćak Jembrek M; Slade N; Hof PR; Šimić G
Prog Neurobiol; 2018 Sep; 168():104-127. PubMed ID: 29733887
[TBL] [Abstract][Full Text] [Related]
30. Seaweed as a source of novel nutraceuticals: sulfated polysaccharides and peptides.
Jiménez-Escrig A; Gómez-Ordóñez E; Rupérez P
Adv Food Nutr Res; 2011; 64():325-37. PubMed ID: 22054959
[TBL] [Abstract][Full Text] [Related]
31. Application of yeast to study the tau and amyloid-β abnormalities of Alzheimer's disease.
Porzoor A; Macreadie IG
J Alzheimers Dis; 2013; 35(2):217-25. PubMed ID: 23396350
[TBL] [Abstract][Full Text] [Related]
32. Beta-Amyloid and Tau-Protein: Structure, Interaction, and Prion-Like Properties.
Tatarnikova OG; Orlov MA; Bobkova NV
Biochemistry (Mosc); 2015 Dec; 80(13):1800-19. PubMed ID: 26878581
[TBL] [Abstract][Full Text] [Related]
33. MicroRNA in Alzheimer's disease revisited: implications for major neuropathological mechanisms.
Dehghani R; Rahmani F; Rezaei N
Rev Neurosci; 2018 Feb; 29(2):161-182. PubMed ID: 28941357
[TBL] [Abstract][Full Text] [Related]
34. Exploring the potential of marine microbes in clinical management of Alzheimer's disease: A road map for bioprospecting and identifying promising isolates.
Muralidharan A; Josyula VR; Hariharapura RC
Life Sci; 2018 Sep; 208():149-160. PubMed ID: 30031811
[TBL] [Abstract][Full Text] [Related]
35. The search for improved animal models of Alzheimer's disease and novel strategies for therapeutic intervention.
Li C; Briner A; Götz J
Future Med Chem; 2019 Aug; 11(15):1853-1857. PubMed ID: 31517531
[No Abstract] [Full Text] [Related]
36. The modulation of metal bio-availability as a therapeutic strategy for the treatment of Alzheimer's disease.
Crouch PJ; White AR; Bush AI
FEBS J; 2007 Aug; 274(15):3775-83. PubMed ID: 17617225
[TBL] [Abstract][Full Text] [Related]
37. Role of TREM2 in Alzheimer's Disease and its Consequences on β- Amyloid, Tau and Neurofibrillary Tangles.
Singh AK; Mishra G; Maurya A; Awasthi R; Kumari K; Thakur A; Rai A; Rai GK; Sharma B; Kulkarni GT; Singh SK
Curr Alzheimer Res; 2019; 16(13):1216-1229. PubMed ID: 31481003
[TBL] [Abstract][Full Text] [Related]
38. Monocytes in the Peripheral Clearance of Amyloid-β and Alzheimer's Disease.
Guo H; Zhao Z; Zhang R; Chen P; Zhang X; Cheng F; Gou X
J Alzheimers Dis; 2019; 68(4):1391-1400. PubMed ID: 30958361
[TBL] [Abstract][Full Text] [Related]
39. Synaptic dysfunction in Alzheimer's disease: Mechanisms and therapeutic strategies.
Chen Y; Fu AKY; Ip NY
Pharmacol Ther; 2019 Mar; 195():186-198. PubMed ID: 30439458
[TBL] [Abstract][Full Text] [Related]
40. Overcoming translational barriers impeding development of Alzheimer's disease modifying therapies.
Golde TE
J Neurochem; 2016 Oct; 139 Suppl 2(Suppl 2):224-236. PubMed ID: 27145445
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
